Abstract
Background—Anecdotal reports suggesting that survival rates among hospitalized patients with Ebola
virus disease in Guinea are higher than the 29.2% rate observed in the current epidemic in West Africa.
Methods—Survival after symptom onset was determined using Kaplan Meier survival methods among
patients with confirmed Ebola virus disease treated in Conakry, Guinea from March 25, 2014, to August 5,
2014. We analyzed the relationship between survival and patient factors, including demographics and clinical features.
Results—Of the 70 patients analyzed [mean age ± standard deviation (SD), 34 ± 14.1; 44 were men], 42
were discharged alive with a survival rate among hospitalized patients of 60% (95% confidence interval,
41.5–78.5%). The survival rate was 28 (71.8%) among 39 patients under 34 years of age, and 14 (46.7%)
among 30 patients aged 35 years or greater (p = 0.034). The rates of myalgia (3 of 42 versus 7 of 28, p =
0.036) and hiccups (1 of 42 versus 5 of 28, p = 0.023) were significantly lower among patients who survived.
Conclusions—Our results provide insights into a cohort of hospitalized patients with Ebola virus disease
in whom survival is prominently higher than seen in other cohorts of hospitalized patients
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Journal of Vascular and Interventional Neurology